Product NDC: | 0270-0556 |
Proprietary Name: | KINEVAC |
Non Proprietary Name: | sincalide |
Active Ingredient(s): | 5 ug/5mL & nbsp; sincalide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0270-0556 |
Labeler Name: | Bracco Diagnostics Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017697 |
Marketing Category: | NDA |
Start Marketing Date: | 19760721 |
Package NDC: | 0270-0556-15 |
Package Description: | 10 VIAL in 1 PACKAGE (0270-0556-15) > 5 mL in 1 VIAL |
NDC Code | 0270-0556-15 |
Proprietary Name | KINEVAC |
Package Description | 10 VIAL in 1 PACKAGE (0270-0556-15) > 5 mL in 1 VIAL |
Product NDC | 0270-0556 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sincalide |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19760721 |
Marketing Category Name | NDA |
Labeler Name | Bracco Diagnostics Inc. |
Substance Name | SINCALIDE |
Strength Number | 5 |
Strength Unit | ug/5mL |
Pharmaceutical Classes | Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] |